Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1Breast 1

Conditions

Osteoporosis 1Myocardial Ischemia 1Heart Diseases 1Coronary Disease 1Colonic Neoplasms 1Cardiovascular Diseases 1Breast Neoplasms 1Bone Diseases 1

Interventions

palbociclib 2Blood Pressure 2xinmailong 1ribociclib 1abemaciclib 1Vitamin D 1Social Determinants of Health 1Rivaroxaban 1Restraint, Physical 1Raloxifene Hydrochloride 1Quality of Life 1Progestins 1Progesterone 1Positron-Emission Tomography 1Patient Navigation 1Linseed Oil 1Hormone Replacement Therapy 1High-Intensity Interval Training 1Heart Rate 1Heart Function Tests 1Genetic Testing 1Exercise 1Estrogens 1Estrogen Replacement Therapy 1Estradiol 1Dietary Supplements 1Diet, Fat-Restricted 1Calcium 1Anthracyclines 1Absorptiometry, Photon 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cardiovascular Diseases × Estrogen Replacement Therapy × Breast × Clear all
NCT00000611 2016-04-15

Women's Health Initiative (WHI)

National Heart, Lung, and Blood Institute (NHLBI)

Phase 3 Completed
BreastGastrointestinal

Bone Diseases, Breast Neoplasms, Cardiovascular Diseases, Colonic Neoplasms, Coronary Disease, Heart Diseases, Osteoporosis, Myocardial Ischemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡